These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Kopp JB, Winkler CA, Nelson GW. Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613 [Abstract] [Full Text] [Related]
25. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans. Gutiérrez OM, Judd SE, Irvin MR, Zhi D, Limdi N, Palmer ND, Rich SS, Sale MM, Freedman BI. Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403 [Abstract] [Full Text] [Related]
26. Association between MYH9 and APOL1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes in a Chinese Han Population. Zhao H, Ma L, Yan M, Wang Y, Zhao T, Zhang H, Liu P, Liu Y, Li P. J Diabetes Res; 2018 Apr; 2018():5068578. PubMed ID: 29862302 [Abstract] [Full Text] [Related]
38. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Anyaegbu EI, Shaw AS, Hruska KA, Jain S. Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085 [Abstract] [Full Text] [Related]